Published in J Interv Card Electrophysiol on June 01, 2002
Spontaneous transition from atrial fibrillation to typical atrial flutter during catheter ablation of the pulmonary vein. J Interv Card Electrophysiol (2004) 1.09
Hybrid therapy of atrial fibrillation: algorithms and outcome. J Interv Card Electrophysiol (2003) 0.75
The role of pacing in rhythm control and management of atrial fibrillation. J Interv Card Electrophysiol (2007) 0.75
Classifications and practice guidelines in atrial fibrillation: a changing landscape. J Interv Card Electrophysiol (2003) 0.75
Rationale and patient selection for "hybrid" drug and device therapy in atrial and ventricular arrhythmias. J Interv Card Electrophysiol (2003) 0.75
A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation (1997) 4.05
High-density mapping of electrically induced atrial fibrillation in humans. Circulation (1994) 2.94
Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol (1996) 2.27
Role of right atrial endocardial structures as barriers to conduction during human type I atrial flutter. Activation and entrainment mapping guided by intracardiac echocardiography. Circulation (1995) 2.14
Catheter ablation of the atrial myocardium in human type I atrial flutter. Circulation (1990) 1.93
Five-year experience with the maze procedure for atrial fibrillation. Ann Thorac Surg (1993) 1.65
Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal-averaged electrocardiography: a prospective study. Circulation (1997) 1.55
Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the Worldwide Jewel AF Investigators. Circulation (2000) 1.37
Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol (1998) 1.36
Regional right and left atrial activation patterns during single- and dual-site atrial pacing in patients with atrial fibrillation. Am J Cardiol (1998) 1.26
Acute effects of dual-site right atrial pacing in patients with spontaneous and inducible atrial flutter and fibrillation. J Am Coll Cardiol (1997) 1.24
Relationship between atrial fibrillation and typical atrial flutter in humans: activation sequence changes during spontaneous conversion. Circulation (1997) 1.08
The risk of atrial fibrillation following radiofrequency catheter ablation of atrial flutter. Circulation (1995) 1.08
Mapping the conversion of atrial flutter to atrial fibrillation and atrial fibrillation to atrial flutter. Insights into mechanisms. Circ Res (1994) 1.07
Electrophysiology and endocardial mapping of induced atrial fibrillation in patients with spontaneous atrial fibrillation. Am J Cardiol (1999) 1.02
Radiofrequency ablation of "class IC atrial flutter" in patients with resistant atrial fibrillation. Am J Cardiol (1999) 0.97
Ablation therapy of type I atrial flutter may eradicate paroxysmal atrial fibrillation. Am J Cardiol (1996) 0.94
Conduction barriers in human atrial flutter: correlation of electrophysiology and anatomy. J Cardiovasc Electrophysiol (1996) 0.91
Progression of permanent atrial fibrillation after atrioventricular junction ablation and dual-chamber pacemaker implantation in patients with paroxysmal atrial tachyarrhythmias. Am J Cardiol (1998) 0.87
The results of atrial flutter ablation in patients with and without a history of atrial fibrillation. Am J Cardiol (1996) 0.85
Prospective clinical evaluation of a programmed atrial stimulation protocol for induction of sustained atrial fibrillation and flutter. J Interv Card Electrophysiol (1999) 0.83
Right and left atrial activation during external direct-current cardioversion shocks delivered for termination of atrial fibrillation in humans. Am J Cardiol (2001) 0.78
Benefits of new catheter mapping technology: fact or fiction? J Interv Card Electrophysiol (2000) 0.78
Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm (2005) 1.94
Biatrial and three-dimensional mapping of spontaneous atrial arrhythmias in patients with refractory atrial fibrillation. J Cardiovasc Electrophysiol (2005) 1.67
Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposure. Ann Allergy Asthma Immunol (2004) 1.43
Prediction of long-term outcome after primary percutaneous coronary intervention for acute anterior myocardial infarction. Kardiol Pol (2010) 1.42
Recurrence of ventricular arrhythmias in patients with non-ischaemic dilated cardiomyopathy: evidence-based predictors. Kardiol Pol (2009) 1.39
Risk factors of asymptomatic restenosis in patients with first anterior ST elevation myocardial infarction treated by primary percutaneous coronary intervention. Kardiol Pol (2010) 1.39
NASPE policy statement on catheter ablation: personnel, policy, procedures, and therapeutic recommendations. Pacing Clin Electrophysiol (2003) 1.20
Progression of new onset to established persistent atrial fibrillation: an implantable device-based analysis with implications for clinical classification of persistent atrial fibrillation. J Interv Card Electrophysiol (2011) 1.09
Clinical trials of antiarrhythmic therapies and optimizing health care resource deployment: the need for a paradigm shift. J Interv Card Electrophysiol (2012) 1.04
International consensus on nomenclature and classification of atrial fibrillation: A collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol (2003) 0.98
Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis. Ann Allergy Asthma Immunol (2005) 0.95
Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol (2002) 0.95
Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast. Ann Allergy Asthma Immunol (2006) 0.94
Intermittent or daily montelukast versus placebo for episodic asthma in children. Ann Allergy Asthma Immunol (2011) 0.91
Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis. Ann Allergy Asthma Immunol (2003) 0.91
Effect of montelukast for treatment of asthma in cigarette smokers. J Allergy Clin Immunol (2013) 0.90
A truly new view from the summit: from translational science to outcomes research in clinical arrhythmology. J Interv Card Electrophysiol (2010) 0.85
Impact of "hybrid therapy" on long-term rhythm control and arrhythmia related hospitalizations in patients with drug-refractory persistent and permanent atrial fibrillation. J Interv Card Electrophysiol (2007) 0.85
Validation of the nighttime symptoms score as a clinically relevant measure of allergic rhinitis. Allergy Asthma Proc (2006) 0.83
Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies. Ann Allergy Asthma Immunol (2004) 0.82
QT/RR relationship in patients after remote anterior myocardial infarction with left ventricular dysfunction and different types of ventricular arrhythmias. Ann Noninvasive Electrocardiol (2008) 0.81
Prediction of left ventricular remodeling in patients with STEMI treated with primary PCI: use of quantitative myocardial contrast echocardiography. Coron Artery Dis (2011) 0.81
Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation. Am J Cardiol (2004) 0.81
Bundle branch block and cardiac resynchronization therapy: do we need to look further before we leap? J Interv Card Electrophysiol (2003) 0.80
Predictive value of ischemic mitral regurgitation during the acute phase of ST elevation myocardial infarction treated with primary coronary intervention for left ventricular remodeling in long-term follow-up. Coron Artery Dis (2010) 0.80
Implantable rhythm management device failures and patient/physician notification: a simmering cauldron boils over. J Interv Card Electrophysiol (2005) 0.79
Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis. Am J Rhinol (2006) 0.79
Microvascular damage prevention with thrombaspiration during primary percutaneous intervention in acute myocardial infarction. Coron Artery Dis (2009) 0.79
Calamities and cardiac arrhythmias: the medical and scientific impact of epidemics of suffering. J Interv Card Electrophysiol (2002) 0.79
Effectiveness of rhythm control in persistent or permanent atrial fibrillation with overdrive atrial pacing and antiarrhythmic drugs after linear right atrial catheter ablation. Am J Cardiol (2003) 0.79
Reducing mortality in patients with advanced cardiovascular disease: subgroups, subgroups and more subgroups... J Interv Card Electrophysiol (2004) 0.78
A statement on ethics from the HEART Group. JACC Cardiovasc Imaging (2008) 0.78
[Long QT syndrome in the postpartum period]. Kardiol Pol (2009) 0.78
Predictors of long-term outcome in patients with left ventricular dysfunction following coronary artery bypass grafting. Kardiol Pol (2008) 0.78
Relationship between duration of repolarisation and T wave amplitude in patients with positive or negative T wave alternans. Kardiol Pol (2005) 0.78
The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity. J Asthma (2009) 0.78
Comments on Mougey et al. (2009): Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response. Pharmacogenet Genomics 19: 129-138. Pharmacogenet Genomics (2012) 0.78
Effect of postconditioning on infarction size, adverse left ventricular remodeling, and improvement in left ventricular systolic function in patients with first anterior ST‑segment elevation myocardial infarction. Pol Arch Med Wewn (2013) 0.78
Dual site right atrial pacing can improve the impact of standard dual chamber pacing on atrial and ventricular mechanical function in patients with symptomatic atrial fibrillation: further observations from the dual site atrial pacing for prevention of atrial fibrillation trial. J Interv Card Electrophysiol (2005) 0.77
Onset and duration of attenuation of exercise-induced bronchoconstriction in children by single-dose of montelukast. Allergy Asthma Proc (2012) 0.77
Onset of efficacy of montelukast in seasonal allergic rhinitis. Allergy Asthma Proc (2005) 0.77
Left atrial reverse remodeling and prevention of progression of atrial fibrillation with atrial resynchronization device therapy utilizing dual-site right atrial pacing in patients with atrial fibrillation refractory to antiarrhythmic drugs or catheter ablation. J Interv Card Electrophysiol (2014) 0.77
Mutational screening of SCN5A linked disorders in Polish patients and their family members. J Appl Genet (2004) 0.76
Patients with atrial fibrillation and low risk of stroke: do they really need anticoagulation? Pol Arch Med Wewn (2015) 0.76
Prophylactic ICDs: can (and will) the medical marketplace decide their role? J Interv Card Electrophysiol (2005) 0.75
Federal guidelines for prophylactic ICD therapy in high risk populations for sudden cardiac death: is this a necessary course correction? J Interv Card Electrophysiol (2005) 0.75
Could we improve thromboembolic risk stratification in patients with atrial fibrillation? Pol Arch Med Wewn (2015) 0.75
Implantable cardioverter-defibrillators in cardiovascular care: technologic advances and new indications. Curr Opin Crit Care (2003) 0.75
Postextrasystolic repolarization abnormalities in ST-U segment in patients with ventricular arrhythmias. Ann Noninvasive Electrocardiol (2002) 0.75
[Prediction of adverse cardiac events in patients with acute anterior wall myocardial infarction treated with PCI]. Pol Arch Med Wewn (2006) 0.75
Atrial fibrillation: is the fog lifting? J Interv Card Electrophysiol (2006) 0.75
Twenty years of interventional cardiac electrophysiology: Meeting future challenges with continuing innovations. J Interv Card Electrophysiol (2011) 0.75
Peering through the looking glass: electrical therapy for atrial fibrillation in 2004--where do we stand? J Cardiovasc Electrophysiol (2004) 0.75
CRT-P for ineffective RV pacing in variant angina. Kardiol Pol (2014) 0.75
[Left ventricular non-compaction: how to identify and treat? A case report]. Kardiol Pol (2006) 0.75
The use of myocardial contrast echocardiography in the assessment of left ventricular function recovery after primary percutaneous coronary intervention in the setting of acute myocardial infarction. Kardiol Pol (2006) 0.75
Berndt Lüderitz (1940-present). J Interv Card Electrophysiol (2005) 0.75
Congenital malformations among infants born to women receiving montelukast, inhaled corticosteroids, and other asthma medications. J Allergy Clin Immunol (2011) 0.75
Ragweed skin test responsiveness correlates with specific immunoglobulin E levels. Allergy Asthma Proc (2005) 0.75
Impact of left ventricular remodeling on ventricular repolarization and heart rate variability in patients after myocardial infarction treated with primary PCI: prospective 6 months follow-up. Ann Noninvasive Electrocardiol (2008) 0.75
Every man and woman's guide to cardiac arrhythmias: what should Mr. & Ms. John Q Public know? J Interv Card Electrophysiol (2002) 0.75
Intra-cardiac echocardiography guided cardioversion to help interventional procedures (ICE-CHIP) study: study design and methods. J Interv Card Electrophysiol (2005) 0.75
Real time online imaging for interventional electrophysiologists: many directions and extraordinary opportunities. J Interv Card Electrophysiol (2006) 0.75
Implantable defibrillators for heart failure: a siren's song or a brave new world? J Interv Card Electrophysiol (2002) 0.75
Implantable defibrillators configured for hybrid therapy of persistent and permanent atrial fibrillation: initial clinical experience with a novel lead system. J Interv Card Electrophysiol (2005) 0.75
Diagnostic utility of tissue tracking echocardiography for the diagnosis of ischaemic heart disease. Kardiol Pol (2006) 0.75
Correlation between electrical and mechanical properties of the left ventricle in patients with postinfarction ventricular tachycardia. Kardiol Pol (2007) 0.75
Dynamicity of early and late phases of repolarization in patients with remote anterior myocardial infarction: the interlead differences. Ann Noninvasive Electrocardiol (2012) 0.75
Survival of antiarrhythmic or implantable cardioverter defibrillator treated patients with varying degrees of left ventricular dysfunction who survived malignant ventricular arrhythmias. J Cardiovasc Electrophysiol (2002) 0.75
[Incessant ventricular tachycardia in a patient with a severe aortic stenosis successfully treated by cardiac surgery]. Kardiol Pol (2006) 0.75
The leadless defibrillator or the return of the subcutaneous electrode: episode III in the ICD saga? J Interv Card Electrophysiol (2005) 0.75
Proceedings of the 7th International Symposium on Interventional Electrophysiology. Foreword. J Interv Card Electrophysiol (2014) 0.75